Daisuke Morishita

3PUBLICATIONS
71CO-AUTHORS
Molecular targetsPredictive and prognostic markersEconometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 18, 2026
Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.

|Mar 12, 2026
A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinoma.

Shunsuke Kawahara, Mana Taki, Junzo Hamanishi

|Jul 15, 2022
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.

June Takeda, Kenichi Yoshida, Masahiro M Nakagawa

Pageof 1